David Anderson, Joins Pittsburgh-Based Contract Research Organization, Clinical Research Strategies, LLC as Clinical Research Associate
Pittsburgh, PA – January 19, 2022. Clinical Research Strategies, LLC (“CRS”), a Pittsburgh-area-based, US-owned and operated contract research organization (CRO) and executive management consultancy for the life sciences industry is pleased to announce the addition of David Anderson to the firm as a Clinical Research Associate. Mr. Anderson is a recent graduate from the Indiana University of Pennsylvania, earning a dual bachelor’s degree in biology and anthropology with GPA of 3.5 and a minor in Global Health.
David has special training and certification in mental health and naloxone administration with a focus on populations who are underserved or forgotten in our communities. As consul president of Kappa Delta Rho, David made a difference in policy reform for the fraternity on a national level. Additionally, Mr. Anderson was a tutor in the American Language Institute where he led initiatives to improve US culture, customs, and norms.
Pursuing a career in research was an idea passed along to David by a favorite anthropology professor.
Alethea Wieland, President and Co-founder states, “David has great character pursuing an early collegiate interest in healthcare including with disadvantaged populations who carry an unfair stigma surrounding drug use and mental health. He has learned a powerful lesson that the mission of research is to improve access to everyone.” CRS CEO and Chief Quality and Regulatory Officer, David Link, MBA, adds, “We are excited about the addition of a newcomer to our team who already has a deep appreciation for the transformational work we do with industry and our clients.”
About Clinical Research Strategies, LLC:
CRS is a specialty CRO and executive management consulting firm that fits-for-purpose veteran life sciences executives, attorneys, regulatory scientists and strategists, clinical operations, project management, quality assurance engineers, and sales and marketing teams to take on the biggest challenges for start-up, mid-sized, and large life sciences companies, many of whom are developing novel, first-in-class drugs, biologics, diagnostics and medical devices, or software as a medical device (SaMD). Service areas are clinical trials, Functional Service Provider (FSP) models, selection and management of CROs, regulatory compliance strategy and submissions, QMS, EU MDR and GDPR, rescue trials, TMF, risk mitigation and remediation, training high-performing teams, staffing solutions, and decentralized trials.
Indications represented are precision medicine, immuno-oncology, central nervous system, infectious diseases, respiratory diseases, orthopedics, de novo devices, digital health and mobile apps, reproductive health, regenerative medicine, cardiology, major depressive disorder, opioid-sparing pain, cannabis, radiology, and critical care. CRS is a qualified service provider for federal grants.
CRS is an inclusive employer and does not discriminate in employment on the basis of race, color, religion, sex, gender identity, national origin, political affiliation, sexual orientation, marital status, disability, genetic information, age, education, membership in an employee organization, parental status, military service, or other non-merit factor. CRS does not tolerate censorship, surveillance, bullying, intimidation, retaliation, discrimination, or harassment of any kind.
# # #
Step2 Branding & Design
Alethea Wieland, President and Founder
Clinical Research Strategies, LLC